“They are professional, very helpful, and quick response. I highly recommend their service for your immigration application.”
General Field: Pharmaceutics
Position at the Time of Case Filing: Researcher
Country of Origin: China
State of Residence at the Time of Filing: Minnesota
Approval Notice Date: September 19th, 2019
Processing Time: 8 Days (Premium Processing Requested)
A pharmaceutics researcher from China hired North America Immigration Law Group (NAILG) to put together and file an EB-1B (Outstanding Professors and Researchers) petition on his behalf. As EB-1B is an employer-sponsored visa category, our client had to garner his employer’s full support before signing the retainer agreement. His employer—an American university—offered their full support and provided our firm with all the necessary paperwork needed to represent our client. To build a strong case, our legal team carefully reviewed his credentials and claimed the following criteria – original contributions of major significance in the field, authorship, and judge of the other’s work.
To demonstrate that he has fulfilled the first criteria, our team collected extensive documentary evidence to prove that he not only qualifies as an outstanding researcher, but also that he is recognized internationally for his accomplishments within the field. As an advanced degree professional in the field of pharmaceutics, our client focuses his research on crystal engineering and formulation. His work on understanding the availability and formulation of various therapeutic compounds has made substantial impact on the field of by improving treatments and patient adherence to treatments for a variety of conditions. In one of his notable projects, his proposed applications through characterizing and formulating new pharmaceuticals have improved the palatability of current medication. His findings enabled experts in the field to design and develop drugs that not only taste better, but are more resilient and long-lasting. This proves the pioneering nature and the significant impact his research had in this area.
In evidence of the beneficiary’s authorship, our client has published 26 peer-reviewed scientific articles. At the time of filing, these works have accumulated 159 citations in other peer-reviewed journals. This citation record assuredly demonstrates that he is among the top in the field. Our client has also conducted 50 reviews which proved his active participation as a judge of the work of others.
We also asked our client to reach out to other experts in the field of pharmaceutics who were familiar with his studies so that they could provide him with recommendation letters. Our client secured five letters, one of which stated: “The consistency with which [Client]’s research has appeared in journals of such high standing makes a powerful statement regarding the quality of his work and its value to other experts within the field.”
Due to the swift adjudication guaranteed by Premium Processing (PP) services, we received the approval notice just 8 days later. Now that our client’s I-140 petition is approved, he will file an I-485 application to secure a green card as he is based inside the US. We wish him the best with this final step and thank him for choosing us to represent his EB-1B case. It was a pleasure working with him and we wish him the very best as he continues to conduct effective research in the field of pharmaceutics.
North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability) and EB1-B (Outstanding Researcher/Professor).
Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend
With 12,000 EB-1A, EB-1B and EB-2 NIW approvals, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.
We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours
With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.
Vast Majority of Clients Came to Us Because of Referrals
For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approvals grew from 600 in 2013 to more than 3,000 in 2017.
Approval Notices: https://www.wegreened.com/eb1_niw_approvals
Success Stories: https://blog.wegreened.com/
Free evaluation email: firstname.lastname@example.org
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to: